Home > National Drug Code (NDC) > SK-II Facial Treatment

SK-II Facial Treatment - 37000-731-30 - (Octinoxate)

Alphabetical Index


Drug Information of SK-II Facial Treatment

Product NDC: 37000-731
Proprietary Name: SK-II Facial Treatment
Non Proprietary Name: Octinoxate
Active Ingredient(s): 10.9; 81.64; 42.728    mg/mL; mg/mL; mg/mL & nbsp;   Octinoxate
Administration Route(s): TOPICAL
Dosage Form(s): LOTION
Coding System: National Drug Codes(NDC)

Labeler Information of SK-II Facial Treatment

Product NDC: 37000-731
Labeler Name: Procter & Gamble Manufacturing Co.
Product Type: HUMAN OTC DRUG
FDA Application Number: part352
Marketing Category: OTC MONOGRAPH FINAL
Start Marketing Date: 20091101

Package Information of SK-II Facial Treatment

Package NDC: 37000-731-30
Package Description: 1 BOTTLE, DISPENSING in 1 CARTON (37000-731-30) > 30 mL in 1 BOTTLE, DISPENSING

NDC Information of SK-II Facial Treatment

NDC Code 37000-731-30
Proprietary Name SK-II Facial Treatment
Package Description 1 BOTTLE, DISPENSING in 1 CARTON (37000-731-30) > 30 mL in 1 BOTTLE, DISPENSING
Product NDC 37000-731
Product Type Name HUMAN OTC DRUG
Non Proprietary Name Octinoxate
Dosage Form Name LOTION
Route Name TOPICAL
Start Marketing Date 20091101
Marketing Category Name OTC MONOGRAPH FINAL
Labeler Name Procter & Gamble Manufacturing Co.
Substance Name ENSULIZOLE; OCTINOXATE; ZINC OXIDE
Strength Number 10.9; 81.64; 42.728
Strength Unit mg/mL; mg/mL; mg/mL
Pharmaceutical Classes

Complete Information of SK-II Facial Treatment


General Information